On-Sight Interviews

Duker Sees “Energy” Being Added to Gene Therapy Field

By Tom Salemi | November 30, 2015

Jay Duker, MD, Director of the New England Eye Center and Chairman of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine,…

Read More

Saunders Speaks to Allergan’s Innovative Culture

By Tom Salemi | November 23, 2015

Prior to the announcement of the Pfizer-Allergan combination, Allergan CEO and President Brent Saunders spoke with OISTV about how the pharma industry finds and foster…

Read More

WaveTec CEO Tom Frinzi Hints at Plans for Future

By Tom Salemi | December 5, 2014

WaveTec CEO Tom Frinzi spoke to the ease of the deal that paired his company with Alcon, hints at plans for the future and explains…

Read More

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

By Tom Salemi | December 5, 2014

Laurent Attias, head of Global Commercial Strategy of Alcon, explains why the WaveTec Vision integration has gone so well and how Alcon will maximize the…

Read More

Jeff George’s Vision for Innovation at Alcon

By Tom Salemi | December 5, 2014

Jeff George, Global Head of Alcon, took a few minutes between panels and meetings to share his vision for innovation at Alcon and how the…

Read More

Q&A with Richard Lindstrom

By Tom Salemi | December 3, 2014

First adopter Richard Lindstrom, MD, details the role new technology play in ophthalmology. Speaking With: Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending…

Read More

Q&A with Michael Brownell

By Tom Salemi | December 3, 2014

Michael Brownell, CEO of Gobiquity, explains how his company is turning smartphones into a critical diagonstic tool to treat pediatric vision. Speaking With: Michael Brownell…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.